✦ LIBER ✦

Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer

✍ Scribed by Masayoshi Yasui; Masataka Ikeda; Mitsugu Sekimoto; Hirofumi Yamamoto; Ichiro Takemasa; Takafumi Ueda; Junzo Shimizu; Mutsumi Fukunaga; Osamu Suzuki; Takehiro Inoue; Morito Monden

Book ID: 119903422
Publisher: BioMed Central
Year: 2006
Tongue: English
Weight: 519 KB
Volume: 4
Category: Article
ISSN: 1477-7819
DOI: 10.1186/1477-7819-4-83

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy of biweekly iri

Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients

✍ Koji Okabayashi; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Hiroki Ochia 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 392 KB

Phase I and pharmacokinetic study of iri

Phase I and pharmacokinetic study of irinotecan (CPT-11) given by 24 hours infusion plus oral uracil/tegafur (UFT) in patients with lung cancer

✍ Yamazaki, H.; Hirano, A.; Funakoshi, S.; Kuraishi, Y.; Akiyama, Y.; Sato, T.; Mi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 160 KB

665 PUBLICATION Phase I/II study of 24-h

665 PUBLICATION Phase I/II study of 24-hour infusion of irinotecan (CPT-11) in combination with sequential oral leucovorin (LV) and uracil/tegafur (UFT) for patients with metastatic colorectal cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Randomised phase III trial of adjuvant c

Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205

✍ Shimada, Yasuhiro; Hamaguchi, Tetsuya; Mizusawa, Junki; Saito, Norio; Kanemitsu, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 582 KB

Toxicity and Response of Pemetrexed Plus

Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy (CRT) for Patients with Locally Advanced Non–small-cell Lung Cancer (LANSCLC): A Phase I Trial

✍ J.H. Heinzerling; R.S. Hughes; R. Govindan; J.D. Bradley; J.D. Schiller; G. Peng 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB